Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 67

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 67
---
 trading market, the liquidity of the Placement Agent Warrants will be extremely limited. The common stock issuable upon exercise of
the Placement Agent Warrants is currently listed on the Nasdaq Capital Market.

Right as a Shareholder

Except as otherwise provided
in the Placement Agent Warrants or by virtue of such holder’s ownership of shares of our common stock, the holders of the Placement
Agent Warrants do not have the rights or privileges of holders of our common stock, including any voting rights, until they exercise their
Placement Agent Warrants.

Fundamental Transaction

In the event of a fundamental
transaction, as described in the Placement Agent Warrants and generally including any reorganization, recapitalization or reclassification
of our common stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation
or merger with or into another person, the acquisition of greater than 50% of our outstanding common stock, or any person or group becoming
the beneficial owner of greater than 50% of the voting power represented by our outstanding common stock, the holders of the Placement
Agent Warrants will be entitled to receive upon exercise of the Placement Agent Warrants the kind and amount of securities, cash or other
property that the holders would have received had they exercised the Placement Agent Warrants immediately prior to such fundamental transaction.
In addition, in the event of a fundamental transaction which is approved by our board of directors, the holders of the Placement Agent
Warrants have the right to require us or a successor entity to redeem the Placement Agent Warrant for cash in the amount of the Black-Scholes
value of the unexercised portion of the Placement Agent Warrant on the date of the consummation of the fundamental transaction. In the
event of a fundamental transaction which is not approved by our board of directors, the holders of the Placement Agent Warrants have the
right to require us or a successor entity to redeem the Placement Agent Warrants for the consideration paid in the fundamental transaction
in the amount of the Black Scholes value of the unexercised portion of the Placement Agent Warrant on the date of the consummation of
the fundamental transaction.

Amendments

The Placement Agent Warrants
may be modified or amended with the written consent of the holder of such Placement Agent Warrants and us.

<div align='center'>33

Plan of distribution</div>

We have engaged H.C.
Wainwright & Co., LLC to act as our exclusive placement agent